Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Inventory Average (2016 - 2025)

China Pharma Holdings filings provide 15 years of Inventory Average readings, the most recent being $2.2 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 17.28% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 17.28% decrease, with the full-year FY2025 number at $2.8 million, down 14.69% from a year prior.
  • Inventory Average hit $2.2 million in Q4 2025 for China Pharma Holdings, up from $2.2 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $3.8 million in Q3 2023 to a low of $2.2 million in Q3 2025.
  • Median Inventory Average over the past 5 years was $3.2 million (2022), compared with a mean of $3.1 million.
  • Biggest five-year swings in Inventory Average: soared 58.82% in 2021 and later plummeted 34.98% in 2025.
  • China Pharma Holdings' Inventory Average stood at $3.0 million in 2021, then decreased by 3.1% to $2.9 million in 2022, then rose by 28.53% to $3.7 million in 2023, then dropped by 28.81% to $2.7 million in 2024, then dropped by 17.28% to $2.2 million in 2025.
  • The last three reported values for Inventory Average were $2.2 million (Q4 2025), $2.2 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.